glp-1 receptor agonists GLP1 Receptor Agonists—Effects beyond Obesity
Description
The dynamic nature of anti-obesity (AOM) GLP-1 RA coverage is illustrated by CVS Caremarks formulary change, announced on May 1, 2025 ( 8 )

Orskov C, and Poulsen SS

Patient adoption is also accelerating

doi: 10.1016/j.bbr.2017.11.015 [DOI] [PubMed] [Google Scholar] 119.Mayneris-Perxachs J, Castells-Nobau A, Arnoriaga-Rodrguez M, et al

Why GLP-1 Weight Loss Plateaus Happen Weight loss plateaus happen for a variety of physiological reasons